Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study

Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

“…Our results are similar to a recent international study on outcomes after COVID-19 vaccination in patients with self-reported SLE [ 6 ]. Considering their US data for comparability, SLE patients in that study had a higher prevalence of flares (7/60; 11.6%) and AEs (66.7% after 1st vaccine; 76.9% after 2nd vaccine).…”

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study

“…Instead, we showed that the majority of patients expressing this concern were those with SLE and/or APS, as expected. This implies that we should probably focus more on this subgroup of patients, explaining that there is no additional risk for them [31].…”

The Use of COVID-19 Vaccines in Patients with SLE

“…Another two studies investigated the safety profiles of COVID-19 vaccine specifically in patients with SLE [14,47]. Felten et al surveyed a group of patients with selfreported medically confirmed SLE (n=696) for the occurrence of side effects.…”